•
Jun 30, 2013

West Pharma Q2 2013 Earnings Report

Total Revenue
$345M
Previous year: $325M
+6.1%
EPS
$0.43
Previous year: $0.4
+7.5%
Gross Profit
$111M
Previous year: $98.7M
+12.4%
Cash and Equivalents
$191M
Previous year: $107M
+78.1%
Free Cash Flow
$57.4M
Previous year: $15.2M
+277.6%
Total Assets
$1.61B
Previous year: $1.46B
+10.2%

West Pharma

West Pharma